Faculty

Integration of real-world data and patient-derived organoids to establish precision oncology aimed at elucidating molecular mechanisms, identifying biomarkers, and developing personalized therapies for refractory cancers.

We create molecules to analyze and control biological phenomena, aiming to understand disease mechanisms and realize advanced imaging and drug delivery systems.